From July 1, 2023 to September 30, 2023, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 517,399 shares, representing 3.5% for $0.63 million under the buyback announced on November 10, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1419 USD | -1.73% | -5.02% | -28.33% |
05-20 | Onconetix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-11 | Onconetix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-28.33% | 3.42M | |
+1.43% | 94.45B | |
-0.66% | 38.9B | |
-13.57% | 32.56B | |
+71.74% | 28.34B | |
-12.73% | 15.98B | |
-2.15% | 13.82B | |
-13.59% | 11.34B | |
+158.88% | 9.81B | |
-52.04% | 9.67B |
- Stock Market
- Equities
- ONCO Stock
- News Onconetix, Inc.
- Tranche Update on Blue Water Biotech, Inc.'s Equity Buyback Plan announced on November 10, 2022.